Cytokine storm and the prospects for immunotherapy with COVID-19.
LH Calabrese - Cleveland Clinic journal of medicine, 2020 - europepmc.org
Knowledge about the pathobiology of SARS-CoV-2 as it interacts with immune defenses is
limited. SARS-CoV-2 is spread by droplets that come into contact with mucous membranes …
limited. SARS-CoV-2 is spread by droplets that come into contact with mucous membranes …
[HTML][HTML] Immunomodulation for severe COVID-19 pneumonia: the state of the art
Y Zhang, Y Chen, Z Meng - Frontiers in immunology, 2020 - frontiersin.org
COVID-19 has become a worldwide pandemic caused by the novel coronavirus named
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 …
SARS-CoV-2 in immunocompromised individuals
S DeWolf, JC Laracy, MA Perales, M Kamboj… - Immunity, 2022 - cell.com
Immunocompromised individuals and particularly those with hematologic malignancies are
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
A Copaescu, O Smibert, A Gibson, EJ Phillips… - Journal of Allergy and …, 2020 - Elsevier
The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome
coronavirus 2 presents with a spectrum of clinical manifestations from asymptomatic or mild …
coronavirus 2 presents with a spectrum of clinical manifestations from asymptomatic or mild …
Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses
SC Jordan - Clinical & Experimental Immunology, 2021 - academic.oup.com
The factors responsible for the spectrum of coronavirus 19 (COVID-19) disease severity and
the genesis and nature of protective immunity against COVID-19 remain elusive. Multiple …
the genesis and nature of protective immunity against COVID-19 remain elusive. Multiple …
The pathogenesis of coronavirus-19 disease
AC Borczuk, RK Yantiss - Journal of biomedical science, 2022 - Springer
Severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) is the causal
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …
[HTML][HTML] Covid-19: perspectives on innate immune evasion
The ongoing outbreak of Coronavirus disease 2019 infection achieved pandemic status on
March 11, 2020. As of September 8, 2020 it has caused over 890,000 mortalities world-wide …
March 11, 2020. As of September 8, 2020 it has caused over 890,000 mortalities world-wide …
[HTML][HTML] Humoral immune responses in COVID-19 patients: a window on the state of the art
G Siracusano, C Pastori, L Lopalco - Frontiers in immunology, 2020 - frontiersin.org
The novel SARS-CoV-2 is a recently emerging virus causing a human pandemic. A great
variety of symptoms associated with COVID-19 disease, ranging from mild to severe …
variety of symptoms associated with COVID-19 disease, ranging from mild to severe …
Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm
To the Editor: Since the emergence of Coronavirus Disease 2019 (COVID-19) caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …
The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in countless
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …